Revenue: The sum of all revenue fields included for a company's operating activities.
INmune Bio, Inc. (INMB) had Revenue of $0.01M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-42.08M |
|
-- |
|
$0.01M |
|
$42.65M |
|
$-42.63M |
|
$0.55M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.08M |
|
$-42.63M |
|
$-42.56M |
|
19.94M |
|
19.94M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$22.66M |
|
-- |
|
$16.90M |
|
$39.56M |
|
$7.22M |
|
-- |
|
$0.24M |
|
$7.46M |
|
$32.10M |
|
$15.58M |
|
$32.10M |
|
22.28M |
|
| Cash Flow Statement Financials | |
$-33.36M |
|
-- |
|
$18.21M |
|
$35.85M |
|
$20.92M |
|
$-14.93M |
|
$7.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-304535.70% |
|
-304535.70% |
|
-303971.40% |
|
-300585.70% |
|
-300585.70% |
|
$-33.36M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.04M |
|
-131.11% |
|
-270.05% |
|
-106.37% |
|
-131.11% |
|
$1.44 |
|
$-1.67 |
|
$-1.67 |
|